Bio-Gene Technology Ltd. (AU:BGT) has released an update.
Bio-Gene Technology Ltd. is advancing its strategic priorities, with the scale-up synthesis of its nature-derived insecticide, Flavocide, and the commencement of pilot-scale production in India. The company is on track to file its regulatory dossier for Flavocide in Q4 CY25 and has received patents in Japan and Australia, signaling strong commercial interest and advancements in product development. Additionally, the appointment of Mr. Edmond Tern as CFO and Company Secretary, along with a $504,000 R&D tax incentive, underlines Bio-Gene’s commitment to efficient capital use and international market penetration.
For further insights into AU:BGT stock, check out TipRanks’ Stock Analysis page.